1
|
Zhang X, Mahajan JS, Zhang J, Korley LTJ, Epps TH, Wu C. Lignin-derivable alternatives to bisphenol A with potentially undetectable estrogenic activity and minimal developmental toxicity. Food Chem Toxicol 2024; 190:114787. [PMID: 38838754 DOI: 10.1016/j.fct.2024.114787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2024] [Revised: 04/26/2024] [Accepted: 06/01/2024] [Indexed: 06/07/2024]
Abstract
Lignin-derivable bisguaiacols/bissyringols are viable alternatives to commercial bisphenols; however, many bisguaiacols/bissyringols (e.g., bisguaiacol F [BGF]) have unsubstituted bridging carbons between the aromatic rings, making them more structurally similar to bisphenol F (BPF) than bisphenol A (BPA) - both of which are suspected endocrine disruptors. Herein, we investigated the estrogenic activity (EA) and developmental toxicity of dimethyl-substituted bridging carbon-based lignin-derivable bisphenols (bisguaiacol A [BGA] and bissyringol A [BSA]). Notably, BSA showed undetectable EA at seven test concentrations (from 10-12 M to 10-6 M) in the MCF-7 cell proliferation assay, whereas BPA had detectable EA at five concentrations (from 10-10 M to 10-6 M). In silico results indicated that BSA had the lowest binding affinity with estrogen receptors. Moreover, in vivo chicken embryonic assay results revealed that lignin-derivable monomers had minimal developmental toxicity vs. BPA at environmentally relevant test concentrations (8.7-116 μg/kg). Additionally, all lignin-derivable compounds showed significantly lower expression fold changes (from ∼1.81 to ∼4.41) in chicken fetal liver tests for an estrogen-response gene (apolipoprotein II) in comparison to BPA (fold change of ∼11.51), which was indicative of significantly reduced estrogenic response. Altogether, the methoxy substituents on lignin-derivable bisphenols appeared to be a positive factor in reducing the EA of BPA alternatives.
Collapse
Affiliation(s)
- Xinwen Zhang
- Department of Animal and Food Sciences, University of Delaware, Newark, DE, 19716, USA
| | - Jignesh S Mahajan
- Department of Materials Science and Engineering, University of Delaware, Newark, DE, 19716, USA
| | - Jinglin Zhang
- Department of Animal and Food Sciences, University of Delaware, Newark, DE, 19716, USA
| | - LaShanda T J Korley
- Department of Materials Science and Engineering, University of Delaware, Newark, DE, 19716, USA; Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE, 19716, USA
| | - Thomas H Epps
- Department of Materials Science and Engineering, University of Delaware, Newark, DE, 19716, USA; Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE, 19716, USA
| | - Changqing Wu
- Department of Animal and Food Sciences, University of Delaware, Newark, DE, 19716, USA.
| |
Collapse
|
2
|
Tagne-Fotso R, Riou M, Saoudi A, Zeghnoun A, Frederiksen H, Berman T, Montazeri P, Andersson AM, Rodriguez-Martin L, Akesson A, Berglund M, Biot P, Castaño A, Charles MA, Cocco E, Den Hond E, Dewolf MC, Esteban-Lopez M, Gilles L, Govarts E, Guignard C, Gutleb AC, Hartmann C, Kold Jensen T, Koppen G, Kosjek T, Lambrechts N, McEachan R, Sakhi AK, Snoj Tratnik J, Uhl M, Urquiza J, Vafeiadi M, Van Nieuwenhuyse A, Vrijheid M, Weber T, Zaros C, Tarroja-Aulina E, Knudsen LE, Covaci A, Barouki R, Kolossa-Gehring M, Schoeters G, Denys S, Fillol C, Rambaud L. Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU. ENVIRONMENT INTERNATIONAL 2024; 190:108912. [PMID: 39116556 DOI: 10.1016/j.envint.2024.108912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/14/2024] [Revised: 07/23/2024] [Accepted: 07/23/2024] [Indexed: 08/10/2024]
Abstract
BACKGROUND Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. OBJECTIVE We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. METHODS Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. RESULTS Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. CONCLUSION This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies.
Collapse
Affiliation(s)
- Romuald Tagne-Fotso
- Department of Environmental and Occupational Health, Santé publique France, The French Public Health Agency (SpFrance, ANSP), 12 rue du Val d'Osne, Saint-Maurice Cedex 94415, France.
| | - Margaux Riou
- Department of Environmental and Occupational Health, Santé publique France, The French Public Health Agency (SpFrance, ANSP), 12 rue du Val d'Osne, Saint-Maurice Cedex 94415, France
| | - Abdessattar Saoudi
- Department of Data Support, Data Processing and Analysis, Santé publique France, Saint-Maurice, France
| | - Abdelkrim Zeghnoun
- Department of Data Support, Data Processing and Analysis, Santé publique France, Saint-Maurice, France
| | - Hanne Frederiksen
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
| | - Tamar Berman
- Israel Ministry of Health (MOH-IL), Jerusalem, Israel
| | - Parisa Montazeri
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain
| | - Anna-Maria Andersson
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
| | | | - Agneta Akesson
- Institute of Environmental Medicine, Karolinska Institutet (KI), Stockholm, Sweden
| | - Marika Berglund
- Institute of Environmental Medicine, Karolinska Institutet (KI), Stockholm, Sweden
| | - Pierre Biot
- Federal Public Service Health, Food Chain Safety and Environment, Brussels, Belgium
| | - Argelia Castaño
- National Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - Marie-Aline Charles
- French Institute for Demographic Studies (INED), French Institute for Medical Research and Health (Inserm), French Blood Agency, ELFE Joint Unit, Aubervilliers, France; Inserm UMR 1153, Centre for Research in Epidemiology and Statistics (CRESS), Team Early Life Research on Later Health, University of Paris, Villejuif, France
| | - Emmanuelle Cocco
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg
| | - Elly Den Hond
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Provincial Institute of Hygiene (PIH), Antwerp, Belgium
| | | | - Marta Esteban-Lopez
- National Center for Environmental Health, Instituto de Salud Carlos III (ISCIII), Madrid, Spain
| | - Liese Gilles
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Eva Govarts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Cedric Guignard
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg
| | - Arno C Gutleb
- Environmental Research and Innovation (ERIN) Department, Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg
| | | | - Tina Kold Jensen
- Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark (SDU), Odense, Denmark
| | - Gudrun Koppen
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Tina Kosjek
- Jozef Stefan Institute (JSI), Department of Environmental Sciences, Ljubljana, Slovenia
| | - Nathalie Lambrechts
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium
| | - Rosemary McEachan
- Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom
| | | | - Janja Snoj Tratnik
- Jozef Stefan Institute (JSI), Department of Environmental Sciences, Ljubljana, Slovenia
| | - Maria Uhl
- German Environment Agency (UBA), Berlin, Germany
| | - Jose Urquiza
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain
| | - Marina Vafeiadi
- Department of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece
| | - An Van Nieuwenhuyse
- Department Health Protection, Laboratoire national de santé (LNS), Dudelange, Luxembourg; Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Belgium
| | - Martine Vrijheid
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain
| | - Till Weber
- German Environment Agency (UBA), Berlin, Germany
| | - Cécile Zaros
- French Institute for Demographic Studies (INED), French Institute for Medical Research and Health (Inserm), French Blood Agency, ELFE Joint Unit, Aubervilliers, France
| | | | | | - Adrian Covaci
- Toxicological Center, University of Antwerp, Belgium
| | - Robert Barouki
- Inserm UMR S-1124, University of Paris, T3S, Paris, France; Biochemistry, Metabolomics, and Proteomics Department, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
| | | | - Greet Schoeters
- VITO Health, Flemish Institute for Technological Research (VITO), Mol, Belgium; Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium
| | - Sebastien Denys
- Department of Environmental and Occupational Health, Santé publique France, The French Public Health Agency (SpFrance, ANSP), 12 rue du Val d'Osne, Saint-Maurice Cedex 94415, France
| | - Clemence Fillol
- Department of Environmental and Occupational Health, Santé publique France, The French Public Health Agency (SpFrance, ANSP), 12 rue du Val d'Osne, Saint-Maurice Cedex 94415, France
| | - Loïc Rambaud
- Department of Environmental and Occupational Health, Santé publique France, The French Public Health Agency (SpFrance, ANSP), 12 rue du Val d'Osne, Saint-Maurice Cedex 94415, France
| |
Collapse
|